Previous 10 | Next 10 |
After more than a decade of research and development, pharmaceutical company Trevena (NASDAQ: TRVN) has received its first drug approval from the U.S. Food and Drug Administration (FDA). That is an outstanding achievement, and it sure has attracted a lot of attention. The ...
These Biotech Penny Stocks Pushed higher On Monday; 2 Up Over 115% YTD When the markets are volatile, many turn to penny stocks as an option. These stocks under $5 are generally volatile on their own accord. Many are also less impacted by broader market moves. Just look at one of th...
-- Live presentation highlighting TRV027 as a potential treatment for COVID-19 acute respiratory distress syndrome (ARDS) / abnormal clotting Posters on OLINVYK benefit-risk profile and TRV250 Phase 1 pharmacokinetics -- ...
Are These On Your List Of Penny Stocks To Buy This Week? Have you made your list of penny stocks this week? If you haven’t and are just getting things started, you’ve got your work cut out. There’ve been a lot of discussions over the weekend on what to focus on this week...
Marinus Pharmaceuticals (NASDAQ: MRNS ) +61% after ganaxolone successful in pivot study in rare type of epilepsy. More news on: Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Tiziana Life Sciences PLC, Stocks on the move, , Read more ...
Shares of Trevena (NASDAQ: TRVN) shot higher on Monday following a very bullish analyst report. Guggenheim initiated coverage on the stock, with prognosticator Dana Flanders rating it a buy with a price target of $5.00. Even after Monday's price hike, that level still implies potential upsid...
Gainers: Immunomedics (NASDAQ: IMMU ) +100% . More news on: Immunomedics, Inc., Cassava Sciences, Inc., Vaxart, Inc., Stocks on the move, , Read more ...
Are These Top Penny Stocks To Buy Or Avoid Today? The price of penny stocks can shift in an instant as many of you already know. This is one of the top reasons that these cheap stocks garner so much attention. What’s more, is that so many of these companies tend to captivate interest ...
Immunomedics (NASDAQ: IMMU ) +106% after Gilead to buy the company for $21B (~$88/share). More news on: Immunomedics, Inc., Cassava Sciences, Inc., China Natural Resources, Inc., , Stocks on the move, Read more ...
Does Your List Of Penny Stocks Have These Names On It? If you’re putting together a list of penny stocks right now, how are you building that list? Are you focusing on momentum or looking for fundamental catalysts? Will global events play a role or are you just focusing on company-spe...
News, Short Squeeze, Breakout and More Instantly...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, continues to demonstrate a favorable tolerability profile Ongoing clinical PK study with optimized formulation of TRV045 advances, with data expected 2H 2024 CHESTERBROOK, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- ...
2024-04-02 07:15:05 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for TRVN on April 2, 2024 05:40AM ET. The previous analyst recommendation was Market Outperform. TRVN was trading at $0.4 at issue of the analyst recommendation. Historical Analyst Re...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial support and review of alternatives for OLINVYK CHESTERBROOK, Pa., April 01, 2024 (GL...